n sprigg, kflaherty, jp appleton, ras salman, d bereczki, m beridze, a ciccone, r collins, ra dineen, l duley, jj egea-guerrero, tj england, m karlinski, k krishnan, ac laska, zhe kang law, c ovesen, s ozturk, sj pocock, i roberts, tg robinson,c roffe. (2019). tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the tich-2 rct. - health technology assessement. 1-48. |
nsprigg,kflaherty,jpappleton,rassalman,dbereczki,mberidze,aciccone,rcollins,aczlonkowska,radineen,lduley,jjegea,guerrero,tjengland,kkrishnan,aclaska,zklaw,sozturk,sjpocock,iroberts,tgrobinson,croffe,dseiffge,pscutt,jthanabalan,dwerring,dwhynes,pmbath. (2018). tranexamic acid for hyperacute primary intracerebral haemorrhage (tich-2): an international randomised, placebo-controlled, phase 3 superiority trial. - the lancet. 2107-2115. |
bee hong soon, nor azian abdul murad, sue mian then, azizi abu bakar, farizal fadzilb, jegan thanabalan, mohd saffari mohd haspanic, toh charng jeng, azmi mohd tamil, roslan harun, wan zurinah wan ngah, rahman jamal. (2017). mitochondrial dna mutations in grade ii and iii glioma cell lines are associated with significant mitochondrial dysfunction and higher oxidative stress. - frontiers in physiology. 1-14. |